Since the PI3K/AKT/mTOR pathway is aberrantly active in DLBCL and plays a role in the genesis and progression of DLBCL [365–369], researchers have also investigated its role in PCNSL. The gene discussed is PIK3CD; the disease is diffuse large B-cell lymphoma.